{"commentary":{"count":31,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":22,"podcast":5,"youtube":4},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT00860652\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"RAVES","nct_id":"NCT00860652","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=raves-nct00860652. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 13–40 commentary sources"},"registry":{"acronym":"RAVES","arms":[{"description":"Adjuvant Radiotherapy (64Gy in 32 Fractions to the prostate bed)","label":"Adjuvant Radiotherapy (RT)","type":"EXPERIMENTAL"},{"description":"Active Surveillance with Early Salvage Radiotherapy","label":"Active Surveillance with Early SalvageRT","type":"EXPERIMENTAL"}],"collaborators":["Urological Society of Australia and New Zealand (USANZ)","Australian and New Zealand Urogenital and Prostate Cancer Trials Group"],"completion_date":{"date":"2026-12","type":"ESTIMATED"},"conditions":["Prostate Cancer"],"enrollment":{"count":333,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Adjuvant Radiotherapy","type":"RADIATION"},{"name":"Early Salvage Radiotherapy","type":"RADIATION"}],"last_update":"2022-11-18","lead_sponsor":"Trans Tasman Radiation Oncology Group","official_title":"Radiotherapy - Adjuvant Versus Early Salvage. A Phase III Multi-centre Randomised Trial Comparing Adjuvant Radiotherapy (RT) With Early Salvage RT in Patients With Positive Margins or Extraprostatic Disease Following Radical Prostatectomy.","overall_status":"ACTIVE_NOT_RECRUITING","phases":["NA"],"primary_completion_date":{"date":"2022-12","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Biochemical failure: PSA ≥ 0.4 ng/ml and rising following RT","timeFrame":"After 160 events have been observed, expected to be 5 years after recruitment closes"}],"references":[{"citation":"Kneebone A, Fraser-Browne C, Duchesne GM, Fisher R, Frydenberg M, Herschtal A, Williams SG, Brown C, Delprado W, Haworth A, Joseph DJ, Martin JM, Matthews JHL, Millar JL, Sidhom M, Spry N, Tang CI, Turner S, Wiltshire KL, Woo HH, Davis ID, Lim TS, Pearse M. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. Lancet Oncol. 2020 Oct;21(10):1331-1340. doi: 10.1016/S1470-2045(20)30456-3.","pmid":"33002437","type":"DERIVED"}],"start_date":{"date":"2009-03-03","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Radiotherapy - Adjuvant Versus Early Salvage","url":"https://clinicaltrials.gov/study/NCT00860652"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/raves-nct00860652"}